MABGEL 1: first phase 1 trial of the anti-HIV-1 monoclonal antibodies 2F5, 4E10 and 2G12 as a vaginal microbicide

  • Georgina C Morris
  • , Rebecca C Wiggins
  • , Sarah C Woodhall
  • , J Martin Bland
  • , Carol R Taylor
  • , Vicky Jespers
  • , Brigitta A Vcelar
  • , Charles J Lacey

    Research output: Contribution to journal › A1: Web of Science-article › peer-review

    51 Downloads (Pure)

    Fingerprint

    Dive into the research topics of 'MABGEL 1: first phase 1 trial of the anti-HIV-1 monoclonal antibodies 2F5, 4E10 and 2G12 as a vaginal microbicide'. Together they form a unique fingerprint.

    Pharmacology, Toxicology and Pharmaceutical Science